Resveratrol-Based Gel Application in a Palatal Wound Following Free Gingival Graft Surgery

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 14, 2024

Primary Completion Date

August 30, 2025

Study Completion Date

November 1, 2025

Conditions
Mucogingival Defects
Interventions
DRUG

Resveratrol-Based gel

The Resveratrol-Based gel will be applied using a sterile plastic syringe, and the palatal wound will be immediately covered by an acrylic resin stent. Three days postoperatively, the patients will be recalled, the stent will be removed for evaluation and the Resveratrol gel will be reapplied.

DRUG

Hyaluronic acid gel 0.2%

The 0.2% Hyaluronic acid gel will be applied using a sterile plastic syringe, and the palatal wound will be covered by an acrylic resin stent. Three days postoperatively, the patients will be recalled, the stent will be removed for evaluation, and the Hyaluronic acid gel will be reapplied.

DEVICE

Stent

The palatal wound will be immediately covered by acrylic resin stent three days postoperatively, the patients will be recalled, and the stent will be removed for evaluating the healing of the palatal wound and then recover with stent.

Trial Locations (1)

Unknown

RECRUITING

Faculty of dentistry, Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER